Genetic Analysis AS (XSAT:GEAN)
0.6800
+0.0300 (4.62%)
At close: Aug 6, 2026
Genetic Analysis AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 20.03 | 24.03 | 13.37 | 16.29 | 25.32 | 46.81 |
Cash & Short-Term Investments | 20.03 | 24.03 | 13.37 | 16.29 | 25.32 | 46.81 |
Cash Growth | 87.25% | 79.70% | -17.92% | -35.66% | -45.90% | 93.48% |
Accounts Receivable | 1.16 | 1.91 | 3.2 | 1.9 | 2.61 | 1.05 |
Other Receivables | 5.16 | - | - | 9.33 | 5.75 | 7.37 |
Total Trade Receivables | 6.31 | 1.91 | 3.2 | 11.23 | 8.36 | 8.42 |
Inventory | 1.17 | 0.8 | 0.76 | 1.54 | 1.75 | 2.37 |
Other Current Assets | - | 4.33 | 4.37 | - | - | - |
Total Current Assets | 27.51 | 31.07 | 21.7 | 29.06 | 35.44 | 57.6 |
Net Property, Plant & Equipment | 3.67 | 3.99 | 5.02 | 6.19 | 8.14 | 1.59 |
Other Intangible Assets | 18.03 | 17.44 | 15.71 | 17.83 | 20.85 | 24.31 |
Long-Term Investments | - | - | - | 0.41 | - | - |
Other Long-Term Assets | - | -0.05 | -0.05 | 0.41 | - | - |
Total Assets | 49.21 | 52.45 | 42.38 | 53.49 | 64.42 | 83.49 |
Accounts Payable | 2.02 | 2.56 | 4.68 | 5.59 | 4.62 | 2.41 |
Other Current Liabilities | 15.99 | 16.41 | 7.17 | 10.46 | 8.33 | 7.55 |
Total Current Liabilities | 18.02 | 18.97 | 11.84 | 16.05 | 12.95 | 9.97 |
Long-Term Debt | 6.66 | 3.96 | 4.4 | - | - | 1.1 |
Long-Term Leases | 2.07 | 2.44 | 3.64 | 5.15 | - | 0.33 |
Other Long-Term Liabilities | - | - | - | 10.9 | 7.34 | - |
Total Long-Term Liabilities | 8.72 | 6.4 | 8.04 | 10.9 | 7.34 | 1.43 |
Total Liabilities | 26.74 | 25.37 | 19.88 | 21.49 | 20.28 | 11.4 |
Common Stock | 41.45 | 41.45 | 29.63 | 22.92 | 14.95 | 14.95 |
Additional Paid-in Capital | 11.81 | 11.81 | 7.63 | 9.08 | 29.19 | 57.14 |
Retained Earnings | -30.79 | -26.18 | -14.77 | - | - | 0 |
Shareholders' Equity | 22.47 | 27.08 | 22.49 | 32 | 44.14 | 72.09 |
Total Liabilities & Equity | 49.21 | 52.45 | 42.38 | 53.49 | 64.42 | 83.49 |
Total Debt | 8.72 | 6.4 | 8.04 | 5.15 | 0 | 1.43 |
Net Cash (Debt) | 11.31 | 17.63 | 5.33 | 11.14 | 25.32 | 45.38 |
Net Cash Growth | 299.05% | 230.73% | -52.17% | -55.99% | -44.19% | 87.56% |
Net Cash Per Share | 0.17 | 0.26 | 0.11 | 0.29 | 1.01 | 1.81 |
Book Value | 22.47 | 27.08 | 22.49 | 32 | 44.14 | 72.09 |
Book Value Per Share | 0.33 | 0.39 | 0.46 | 0.84 | 1.76 | 2.88 |
Tangible Book Value | 4.44 | 9.64 | 6.79 | 14.17 | 23.3 | 47.78 |
Tangible Book Value Per Share | 0.07 | 0.14 | 0.14 | 0.37 | 0.93 | 1.91 |